10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
4D Molecular Therapeutics Inc. (FDMT)
Market is closed
Sector: Investment Advice
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 7,382,642 | $79,806,360 | +89% | 2.33% |
| 2. | RA Capital Management Peter Kolchinsky | 5,098,211 | $55,111,661 | 0.63% | |
| 3. | Deep Track Capital David Kroin | 4,096,452 | $44,282,646 | +1% | 1.4% |
| 4. | Redmile Group Jeremy Green | 1,262,090 | $13,643,193 | +18% | 0.8% |
| 5. | Braidwell LP Alex Karnal | 1,225,448 | $13,247,093 | +232% | 0.37% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 850,000 | 4,787,914 | 2023-05-09 | Filing | ||
| $23.00 | 1,100,000 | Large Shareholder | 3,937,914 | 2020-12-15 | Filing | |
| $23.00 | 100,000 | Director | 100,000 | 2020-12-15 | Filing | |
| $23.00 | 4,347 | Officer | 4,347 | 2020-12-15 | Filing | |
| $23.00 | 425,000 | Director | 1,060,880 | 2020-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.33 | 500 | 6,781 | 2024-09-16 | Filing | ||
| $15.00 | 500 | 6,781 | 2024-08-19 | Filing | ||
| $27.11 | 1,750 | 6,781 | 2024-07-16 | Filing | ||
| $25.00 | 1,996 | 6,781 | 2024-07-11 | Filing | ||
| $22.49 | 12,923 | 1,059,153 | 2024-07-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,464,587 | $70,192,532 | 0% | |
| 2. | 3,424,031 | $69,370,868 | 4.75% | |
| 3. | 3,093,296 | $62,681,862 | 0.03% | |
| 4. | 1,866,849 | $37,822,361 | 0% | |
| 5. | 1,568,784 | $31,783,574 | 0% |
News See All
Hedge Fund and Insider Trading News: Bill Ackman, Stanley Druckenmiller, Paul Tudor Jones, Warren Buffett, Elliott Management, QQM Fund Management, Coinbase Global, Inc. (COIN), Cannae Holdings Inc (CNNE), and More
Pershing Square Capital Management, the hedge-fund manager run by billionaire Bill Ackman, built a nearly $1.1 billion stake in Alphabet in the first quarter, a regulatory filing late Monday revealed.
Here's Why 4D Molecular Therapeutics (FDMT) Stock Boosted in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
10 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.
Is 4D Molecular Therapeutics, Inc. (FDMT) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
